Completed PHASE2 INTERVENTIONAL 6-arm NCT02119819

A Study to Compare a New Drug for Type 2 Diabetes to Placebo and to a Treatment Already Available for Type 2 Diabetes

Comparison of the Oxyntomodulin Analog, LY2944876, to Once-Weekly Exenatide and to Placebo in Patients With Type 2 Diabetes

Sponsor: OPKO Health, Inc.

Conditions Diabetes Mellitus, Type 2

Interventions Exenatide extended-release LY2944876 Metformin Placebo

Updated 9 times since 2017 Last updated: May 25, 2021 Started: Apr 30, 2014 Primary completion: Aug 31, 2015 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Diabetes Mellitus, Type 2, this trial is completed. The trial is conducted by OPKO Health, Inc. and has accumulated 9 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jun 2021 — Jul 2024 [monthly]

Completed PHASE2
May 2021 — Jun 2021 [monthly]

Completed PHASE2

▶ Show 4 earlier versions

Jan 2021 — May 2021 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

OPKO Health, Inc.

Data source: OPKO Health, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Altoona, United States , Ampelokipoi, Greece , Athens, Greece , Austin, United States , Bialystok, Poland , Bountiful, United States , Bradenton, United States , Chihuahua City, Mexico , Cluj-Napoca, Romania , Concord, United States and 40 more locations